For years a reliable partner of the pharmaceutical industry
MMM Services s.r.o. is an "affiliate" of Materia Medica Maibach AG (Switzerland) more> on WEB MMM-CH. In order to ensure customer proximity and local idiosyncrasies on the Eastern European markets, in November 2013, MMM Services s.r.o. has commenced operations in Prague. We, from the Prague Team, are competent, respond quickly, are able to listen carefully and to fully perceive customer needs. We develop solutions hand in hand with our customers. When it comes to supporting you in DRA, your relief is our primary goal. That is what we start already in the definition phase. "Outsourcing" should really relieve you in all sub-phases.
Our competencies include services affecting directly or indirectly the authorization of human and animal drugs.
Service products and their characteristics:
Drug Regulatory Compact
Effect on companies, market and customer!
Objective: Minimizing the waste of resources, new markets, optimizing market development, higher product acceptance, more customer trust.
DRA Strategic Agility
Effect on workload, costs, profitability in the life cycle!
Objective: Reducing workload, saving resources, minimizing fees, creating free capacities.
Quality Management
Effect on product quality and safety!
Objective: Controlled processes, higher product quality and safety, high customer satisfaction.
Compliance Management
Effect on costs and profitability!
Objective: Minimizing unnecessary costs, no loss of image, good reputation.
Access to the Swiss Market The wholesale trade authorization of the parent company Materia Medica Maibach AG shall open the access to the Swiss market to you.
Strategy
The claims on the part of regulators, competitors, marketing agents and end consumers (patients) are in a strong transformation phase. Increasing and changing demands represent a real challenge for pharmaceutical companies and their labor contractors. It is our duty to support customers with value-added and sustainable solutions.
We are obligated to exercise discretion towards our customers, therefore we do not publish references. Our business partners include corporations that act as global players as well as large and medium-sized enterprises, which are successfully operating on domestic and international markets.
We generate our sales to 20% on the domestic market and to 80% on the European market.
